Clinical Trial Update: A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] [Phase 3]

View source ↗

Summary

Pfizer is conducting a Phase 3 trial of PF-06823859 to study its effects in people with active idiopathic inflammatory myopathies, specifically Dermatomyositis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis

Drugs mentioned

• PF-06823859

Snippet

Sponsor: Pfizer | Conditions: Myositis | Phase 3 | Status: RECRUITING